Balance Sheet
Accounts PayablesCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Total Long Term Debt: 2018

Historic Total Long Term Debt for Dr Reddys Laboratories (RDY) over the last 1 years, with Mar 2018 value amounting to $741.0 million.

  • Dr Reddys Laboratories' Total Long Term Debt was N/A to $280.0 million in Q4 2020 from the same period last year, while for Dec 2020 it was $280.0 million, marking a year-over-year change of. This contributed to the annual value of $741.0 million for FY2018, which is N/A change from last year.
  • Dr Reddys Laboratories' Total Long Term Debt amounted to $741.0 million in FY2018.
  • Dr Reddys Laboratories' 5-year Total Long Term Debt high stood at $741.0 million for FY2018, and its period low was $741.0 million during FY2018.
  • Its 1-year average for Total Long Term Debt is $741.0 million, with a median of $741.0 million in 2018.